- Home
- LDTC vs LTRN Comparison
LDTC vs LTRN Comparison
Compare LDTC & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDTC
- LTRN
- Stock Information
- Founded
- LDTC 2007
- LTRN 2013
- Country
- LDTC Canada
- LTRN United States
- Employees
- LDTC N/A
- LTRN N/A
- Industry
- LDTC Blank Checks
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- LDTC Finance
- LTRN Health Care
- Exchange
- LDTC Nasdaq
- LTRN Nasdaq
- Market Cap
- LDTC 37.5M
- LTRN 37.2M
- IPO Year
- LDTC N/A
- LTRN 2020
- Fundamental
- Price
- LDTC $0.33
- LTRN $3.29
- Analyst Decision
- LDTC Buy
- LTRN Strong Buy
- Analyst Count
- LDTC 2
- LTRN 1
- Target Price
- LDTC $3.00
- LTRN $25.00
- AVG Volume (30 Days)
- LDTC 279.7K
- LTRN 58.2K
- Earning Date
- LDTC 05-14-2025
- LTRN 05-15-2025
- Dividend Yield
- LDTC N/A
- LTRN N/A
- EPS Growth
- LDTC N/A
- LTRN N/A
- EPS
- LDTC N/A
- LTRN N/A
- Revenue
- LDTC N/A
- LTRN N/A
- Revenue This Year
- LDTC $906.25
- LTRN N/A
- Revenue Next Year
- LDTC $149.88
- LTRN N/A
- P/E Ratio
- LDTC N/A
- LTRN N/A
- Revenue Growth
- LDTC 141.86
- LTRN N/A
- 52 Week Low
- LDTC $0.22
- LTRN $2.55
- 52 Week High
- LDTC $2.75
- LTRN $6.80
- Technical
- Relative Strength Index (RSI)
- LDTC 39.93
- LTRN 42.43
- Support Level
- LDTC $0.28
- LTRN $3.13
- Resistance Level
- LDTC $0.54
- LTRN $4.46
- Average True Range (ATR)
- LDTC 0.08
- LTRN 0.43
- MACD
- LDTC -0.02
- LTRN -0.08
- Stochastic Oscillator
- LDTC 8.86
- LTRN 20.66
About LDTC LeddarTech Holdings Inc.
LeddarTech Holdings Inc is a company that develops and provides comprehensive perception software solutions that enable the deployment of ADAS and autonomous driving (AD) applications. Its automotive-grade software applies AI and computer vision algorithms to generate accurate 3D models of the environment, allowing for decision-making and safer navigation. The company generates the majority of its revenue from France, Canada, and the United states.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.